208 related articles for article (PubMed ID: 33470152)
1. Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage.
Milling TJ; Warach S; Johnston SC; Gajewski B; Costantini T; Price M; Wick J; Roward S; Mudaranthakam D; Dula AN; King B; Muddiman A; Lip GYH
J Neurotrauma; 2021 Jun; 38(13):1791-1798. PubMed ID: 33470152
[TBL] [Abstract][Full Text] [Related]
2. Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials.
King B; Milling T; Gajewski B; Costantini TW; Wick J; Price MA; Mudaranthakam D; Stein DM; Connolly S; Valadka A; Warach S
Trauma Surg Acute Care Open; 2020; 5(1):e000605. PubMed ID: 33313417
[TBL] [Abstract][Full Text] [Related]
3. Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients.
Milling TJ; King B; Yue P; Middeldorp S; Beyer-Westendorf J; Eikelboom JW; Crowther M; Xu L; Verhamme P; Siegal DM; Connolly SJ;
Thromb Haemost; 2021 Aug; 121(8):1097-1106. PubMed ID: 33634446
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage.
Ghenbot Y; Arena JD; Howard S; Wathen C; Kumar MA; Schuster JM
World Neurosurg X; 2023 Jan; 17():100148. PubMed ID: 36407782
[TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of anticoagulation resumption following traumatic brain injury.
Albrecht JS; Liu X; Baumgarten M; Langenberg P; Rattinger GB; Smith GS; Gambert SR; Gottlieb SS; Zuckerman IH
JAMA Intern Med; 2014 Aug; 174(8):1244-51. PubMed ID: 24915005
[TBL] [Abstract][Full Text] [Related]
6. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
7. Risk analysis of thrombo-embolic and recurrent bleeding events in the management of intracranial haemorrhage due to oral anticoagulation.
De Vleeschouwer S; Van Calenbergh F; van Loon J; Nuttin B; Goffin J; Plets C
Acta Chir Belg; 2005; 105(3):268-74. PubMed ID: 16018519
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.
Charidimou A; Wilson D; Shakeshaft C; Ambler G; White M; Cohen H; Yousry T; Al-Shahi Salman R; Lip G; Houlden H; Jäger HR; Brown MM; Werring DJ
Int J Stroke; 2015 Oct; 10 Suppl A100():155-61. PubMed ID: 26235450
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
10. Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage.
Nguyen NY; Frishman WH
Cardiol Rev; 2020; 28(4):190-196. PubMed ID: 31985523
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
[TBL] [Abstract][Full Text] [Related]
12. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study).
Green L; Tan J; Morris JK; Alikhan R; Curry N; Everington T; Maclean R; Saja K; Stanworth S; Tait C; MacCallum P
Haematologica; 2018 Apr; 103(4):738-745. PubMed ID: 29371325
[TBL] [Abstract][Full Text] [Related]
13. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
[TBL] [Abstract][Full Text] [Related]
14. The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.
Smith K; Weeks S
JBI Libr Syst Rev; 2012; 10(58):4610-4621. PubMed ID: 27820526
[TBL] [Abstract][Full Text] [Related]
15. New Target-Specific Oral Anticoagulants and Intracranial Bleeding: Management and Outcome in a Single-Center Case Series.
Senger S; Keiner D; Hendrix P; Oertel J
World Neurosurg; 2016 Apr; 88():132-139. PubMed ID: 26732970
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in the older adult: optimizing benefit and reducing risk.
Ko D; Hylek EM
Semin Thromb Hemost; 2014 Sep; 40(6):688-94. PubMed ID: 25184500
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
Monahan M; Ensor J; Moore D; Fitzmaurice D; Jowett S
J Thromb Haemost; 2017 Aug; 15(8):1591-1600. PubMed ID: 28520199
[TBL] [Abstract][Full Text] [Related]
18. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.
Field TS; Dizonno V; Almekhlafi MA; Bala F; Alhabli I; Wong H; Norena M; Villaluna MK; King-Azote P; Ratnaweera N; Mancini S; Van Gaal SC; Wilson LK; Graham BR; Sposato LA; Blacquiere D; Dewar BM; Boulos MI; Buck BH; Odier C; Perera KS; Pikula A; Tkach A; Medvedev G; Canfield C; Mortenson WB; Nadeau JO; Alshimemeri S; Benavente OR; Demchuk AM; Dowlatshahi D; Lanthier S; Lee AYY; Mandzia J; Suryanarayan D; Weitz JI; Hill MD;
Stroke; 2023 Nov; 54(11):2724-2736. PubMed ID: 37675613
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of clinically relevant delayed intracranial hemorrhage in head trauma patients treated with oral anticoagulants is very low: a retrospective cohort register study.
André L; Björkelund A; Ekelund U; Vedin T; Björk J; Forberg JL
Scand J Trauma Resusc Emerg Med; 2024 May; 32(1):42. PubMed ID: 38730480
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
